Insulin receptor: Difference between revisions
Created page with "The insulin receptor is a heterotetrameric transmembrane protein, composed of two alpha and two beta subunits. The alpha subunits are extracellular, while the beta subunits ..." |
Sorted out the references. Cleaned up the page. |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
The insulin receptor is a heterotetrameric transmembrane protein, composed of two alpha and two beta subunits. The alpha subunits are extracellular, while the beta subunits are intracelluar. The cytosolic face belongs to the large family of receptor tyrosine kinases. Insulin receptors are particularly abundant in adipocytes and muscle cells. Challenge by insulin causes the cytosolic receptor tyrosine kinase to autophosphorylate. The insulin receptor substrate (IRS) molecule can then dock to it, and this in turn acts as a docking station for other proteins with SH2 domains involved in a variety of enzymatic cascades, including the PKB pathway, and the MAP kinase cascade. One of the most important cellular processes that occurs when insulin binds to its receptor is the translocation of | The [[Insulin|insulin]] receptor is a heterotetrameric transmembrane protein, composed of two alpha and two beta subunits. The alpha subunits are extracellular, while the beta subunits are intracelluar. The cytosolic face belongs to the large family of receptor [[Tyrosine kinase|tyrosine kinases]]. Insulin receptors are particularly abundant in [[Adipocyte|adipocytes]] and [[Muscle|muscle]] cells. Challenge by insulin causes the cytosolic receptor tyrosine kinase to [[Autophosphorylate|autophosphorylate]]. The [[Insulin receptor substrate|insulin receptor substrate]] (IRS) molecule can then dock to it, and this, in turn, acts as a docking station for other proteins with [[SH2 domains|SH2 domains]] involved in a variety of enzymatic cascades, including the [[PKB pathway|PKB pathway]], and the [[MAP kinase cascade|MAP kinase cascade]]. One of the most important cellular processes that occurs when insulin binds to its receptor is the translocation of [[GLUT4 vesicles|GLUT4 vesicles]] to the [[Plasma membrane|plasma membrane]], thus allowing greater [[Glucose|glucose]] uptake from the blood. Both the [[Protein kinase B|PKB]] and [[TC10|TC10]] pathways are essential for [[GLUT4|GLUT4]] translocation<ref>Airre V, Uchida T, Yenush L, Davis R, White MF 2000. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047–9054 [PubMed]</ref>. | ||
=== Reference === | |||
<references /><br> | |||
Latest revision as of 08:32, 19 October 2017
The insulin receptor is a heterotetrameric transmembrane protein, composed of two alpha and two beta subunits. The alpha subunits are extracellular, while the beta subunits are intracelluar. The cytosolic face belongs to the large family of receptor tyrosine kinases. Insulin receptors are particularly abundant in adipocytes and muscle cells. Challenge by insulin causes the cytosolic receptor tyrosine kinase to autophosphorylate. The insulin receptor substrate (IRS) molecule can then dock to it, and this, in turn, acts as a docking station for other proteins with SH2 domains involved in a variety of enzymatic cascades, including the PKB pathway, and the MAP kinase cascade. One of the most important cellular processes that occurs when insulin binds to its receptor is the translocation of GLUT4 vesicles to the plasma membrane, thus allowing greater glucose uptake from the blood. Both the PKB and TC10 pathways are essential for GLUT4 translocation[1].
Reference
- ↑ Airre V, Uchida T, Yenush L, Davis R, White MF 2000. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307). J Biol Chem 275: 9047–9054 [PubMed]